LENABASUM, A CB2 AGONIST, INHIBITS INFLAMMASOME ACTIVATION

Chintalacharuvu, S; Zang, P; White, B; Atamas, S

ANNALS OF THE RHEUMATIC DISEASES, 2020; 79 (): 1372